Drugs Made In America Acquisition II Corp. (DMII)
Market Open
12 Jun, 14:49
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 08
0
0%
$
529.35M Market Cap
- P/E Ratio
- Div Yield
3 Volume
- Eps
$ 10.08
Previous Close Want to track DMII and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition II Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Daniel L. Lippincott Karpus Management Inc. | 2.6M | $25.9M | $26.19M | $285,771.79 | 1.1% |
| BO Brian Oliveira Clear Street Group Inc. | 181,521 | $1.8M | $1.83M | $32,673.67 | 1.82% |
| MCS Mercuria Capital Strategies LLC Mercuria Capital Strategies LLC | 750,000 | $7.48M | $7.56M | $82,500 | 1.1% |
| AAS ABC Arbitrage SA ABC Arbitrage SA | 40,000 | $396,000 | $403,200 | $7,200 | 1.82% |
 Mikhail Shilshtut Limestone Investment Advisors LP | 11,900 | $118,643 | $119,952 | $1,309 | 1.1% |
